Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design

Author： Chen Weizao   Ying Tianlei   Dimitrov Dimiter S  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.5, 2013-06, pp. : 657-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibody-based therapeutics for leukemia

By Li Yiwen   Zhu Zhenping  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 319-330

Informa Healthcare

Access to resources Recommend Favorite

Binding of High-Mannose-Type Oligosaccharides and Synthetic Oligomannose Clusters to Human Antibody 2G12 - Implications for HIV-1 Vaccine Design

By Wang L.-X.   Ni J.   Singh S.   Li H.  

Chemistry & Biology, Vol. 11, Iss. 1, 2004-01 ,pp. : 127-134

Elsevier

Access to resources Recommend Favorite

Keystone Symposia: Antibody-based therapeutics for cancer

By Power Barbara   Hudson Peter  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 385-389

Informa Healthcare

Access to resources Recommend Favorite

Elite control of HIV infection: implications for vaccine design

By Baker BM   Block BL   Rothchild AC   Walker BD  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 55-69

Informa Healthcare

Access to resources Recommend Favorite

RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

By Subramanya Sandesh   Kim Sang-Soo   Manjunath N   Shankar Premlata  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 201-213

Informa Healthcare

Access to resources Recommend Favorite